Julia Wolf1, Benito Campos1, Thomas Bruckner2, Lidia Vogt1, Andreas Unterberg1, Rezvan Ahmadi3. 1. Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany. 2. Institute of Medical Bioinformatics, University of Heidelberg, Heidelberg, Germany. 3. Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany. Rezvan.Ahmadi@med.uni-heidelberg.de.
Abstract
PURPOSE: Extended tumour resection is imperative to improve the outcome of glioma patients but also carries the risk of increasing morbidity and thus, potentially, of decreasing the patient's quality of life (QOL). In this pilot study, we evaluated how postoperative neurological and neuropsychological alterations impacted on QOL in patients who underwent glioma resection. METHODS: Twenty-two patients were included in this study and tested at three different time points, i.e. 1 day before surgery (t1), on the day of discharge (t2) and 3 months following surgery (T3). National Institutes of Health Stroke Scale (NIHSS) score, Addenbrook's Cognitive Examination-Revised (ACE-R) and a comprehensive battery of established tests were used to assess neurological and neuropsychological profiles. QOL and subjectively experienced health condition were ascertained through the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC-QLQ C30) and EORTC-QLQ BN20 questionnaires. RESULTS: Postoperatively, 5/22 patients worsened and 5/22 patients improved neurologically. Depending on the neuropsychological test, up to 57.1 % of patients experienced deterioration of some sort of neuropsychological function. Most of these functions, however, recovered during the extended observation period (3 months). There was no correlation between QOL and a patient's neurological or neuropsychological condition. CONCLUSIONS: Our study suggests that extended tumour resection is not necessarily linked to a loss in QOL.
PURPOSE: Extended tumour resection is imperative to improve the outcome of gliomapatients but also carries the risk of increasing morbidity and thus, potentially, of decreasing the patient's quality of life (QOL). In this pilot study, we evaluated how postoperative neurological and neuropsychological alterations impacted on QOL in patients who underwent glioma resection. METHODS: Twenty-two patients were included in this study and tested at three different time points, i.e. 1 day before surgery (t1), on the day of discharge (t2) and 3 months following surgery (T3). National Institutes of Health Stroke Scale (NIHSS) score, Addenbrook's Cognitive Examination-Revised (ACE-R) and a comprehensive battery of established tests were used to assess neurological and neuropsychological profiles. QOL and subjectively experienced health condition were ascertained through the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC-QLQ C30) and EORTC-QLQ BN20 questionnaires. RESULTS: Postoperatively, 5/22 patients worsened and 5/22 patients improved neurologically. Depending on the neuropsychological test, up to 57.1 % of patients experienced deterioration of some sort of neuropsychological function. Most of these functions, however, recovered during the extended observation period (3 months). There was no correlation between QOL and a patient's neurological or neuropsychological condition. CONCLUSIONS: Our study suggests that extended tumour resection is not necessarily linked to a loss in QOL.
Entities:
Keywords:
EORTC-QLQ BN20; EORTC-QLQ C30; Glioma resection; Quality of life
Authors: K Berger; B Weltermann; P Kolominsky-Rabas; S Meves; P Heuschmann; J Böhner; B Neundörfer; H W Hense; T Büttner Journal: Fortschr Neurol Psychiatr Date: 1999-02 Impact factor: 0.752
Authors: David A Reardon; Evanthia Galanis; John F DeGroot; Timothy F Cloughesy; Jeffrey S Wefel; Kathleen R Lamborn; Andrew B Lassman; Mark R Gilbert; John H Sampson; Wolfgang Wick; Marc C Chamberlain; David R Macdonald; Minesh P Mehta; Michael A Vogelbaum; Susan M Chang; Martin J Van den Bent; Patrick Y Wen Journal: Neuro Oncol Date: 2011-02-09 Impact factor: 12.300
Authors: K Bjordal; A de Graeff; P M Fayers; E Hammerlid; C van Pottelsberghe; D Curran; M Ahlner-Elmqvist; E J Maher; J W Meyza; A Brédart; A L Söderholm; J J Arraras; J S Feine; H Abendstein; R P Morton; T Pignon; P Huguenin; A Bottomly; S Kaasa Journal: Eur J Cancer Date: 2000-09 Impact factor: 9.162
Authors: Justin Choon Hwee Ng; Angela An Qi See; Ting Yao Ang; Lysia Yan Rong Tan; Beng Ti Ang; Nicolas Kon Kam King Journal: J Neurooncol Date: 2018-11-16 Impact factor: 4.130
Authors: Christina Weyer-Jamora; Melissa S Brie; Tracy L Luks; Ellen M Smith; Shawn L Hervey-Jumper; Jennie W Taylor Journal: Neurosurgery Date: 2021-11-18 Impact factor: 5.315
Authors: Philip C De Witt Hamer; Philip C De Witt Hamer; Martin Klein; Shawn L Hervey-Jumper; Jeffrey S Wefel; Mitchel S Berger Journal: Neurosurgery Date: 2021-03-15 Impact factor: 4.654
Authors: Sarah Christina Reitz; Marion Behrens; Irina Lortz; Nadine Conradi; Maximilian Rauch; Katharina Filipski; Martin Voss; Christian Kell; Marcus Czabanka; Marie-Therese Forster Journal: Front Oncol Date: 2022-04-07 Impact factor: 5.738
Authors: Eef J Hendriks; Esther J J Habets; Martin J B Taphoorn; Linda Douw; Aeilko H Zwinderman; W Peter Vandertop; Frederik Barkhof; Martin Klein; Philip C De Witt Hamer Journal: Hum Brain Mapp Date: 2018-01-29 Impact factor: 5.038